Healthcare & life sciences
Care infrastructure, healthcare services and innovation. We introduce suitable projects and businesses to potential capital providers, buyers and strategic partners.
Discuss an opportunity ↗Projects, stages and capital
Project types
Healthcare operating businesses, clinics, care facilities, medical technology, diagnostics, pharmaceutical and life-science ventures, and associated property or infrastructure.
Project lifecycle
Growth capital, acquisitions, buy-and-build, asset development and commercial scale-up.
Funding and transaction structures
Growth equity, acquisition finance, asset-backed lending, strategic investment and specialist healthcare capital.
Potential counterparties
Healthcare-focused funds, family offices, specialist lenders, strategic operators and corporate acquirers.
Biotechnology & life sciences
Biotech platforms, diagnostics, drug-development technologies, research-led companies and specialist medical technology. We consider growth equity, strategic partnerships and acquisition opportunities, subject to technical, clinical and regulatory diligence.
The transaction sizes and geographies shown are indicative of the types of opportunities Spoog considers, not published mandates, eligibility thresholds, committed financing or assurances of investor availability. Details are intentionally anonymised. All introductions are subject to suitability, verification, permissions and agreed terms.
Healthcare opportunities and diligence
These are representative transaction considerations informed by the types of opportunities and counterparties we engage with. They are not public listings or claims of completed transactions.
Medical technology and diagnostics
We consider businesses with differentiated diagnostic tools, devices and clinical technology. The regulatory pathway, reimbursement assumptions, intellectual property, clinical evidence and route to market all influence investor suitability.
Pharmaceutical and life-science growth
Research-led businesses may need staged funding linked to technical, clinical or commercial milestones. A strong scientific proposition should be accompanied by a realistic development budget, ownership of IP and an experienced delivery team.
Healthcare services and facilities
Established care or healthcare operating businesses can have different financing needs from pre-revenue biotech. Investors typically assess revenue quality, operating licences, staffing, property exposure and cash generation.
Information for a first discussion
Please provide a non-confidential deck outlining the product or service, development stage, regulatory position, market, management, historic financials where relevant and the precise use of proceeds.
Have an opportunity in healthcare & life sciences?
Send us a high-level summary of the sector, country, project stage and approximate funding requirement. Please do not include confidential documentation in the initial enquiry.
Enquire with Spoog ↗ Investor or lender enquiry ↗